[go: up one dir, main page]

FR2576305B1 - Nouveau procede de fabrication d'un derive d'(aryl substitue)-1 dihydro-1,4 oxo-4 naphtyridine, substances intermediaires utilisees pour cette fabrication et procedes de fabrication des substances intermediaires - Google Patents

Nouveau procede de fabrication d'un derive d'(aryl substitue)-1 dihydro-1,4 oxo-4 naphtyridine, substances intermediaires utilisees pour cette fabrication et procedes de fabrication des substances intermediaires

Info

Publication number
FR2576305B1
FR2576305B1 FR868600871A FR8600871A FR2576305B1 FR 2576305 B1 FR2576305 B1 FR 2576305B1 FR 868600871 A FR868600871 A FR 868600871A FR 8600871 A FR8600871 A FR 8600871A FR 2576305 B1 FR2576305 B1 FR 2576305B1
Authority
FR
France
Prior art keywords
manufacture
intermediate substances
naphtyridine
dihydro
oxo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR868600871A
Other languages
English (en)
Other versions
FR2576305A1 (fr
Inventor
Yozo Todo
Tetsuo Yamafuji
Katsuyuki Nagumo
Isao Kitayama
Hideyoshi Nagaki
Mikako Miyajima
Nee Shinagawa
Yoshinori Konishi
Hirokazu Narita
Shuntaro Takano
Isamu Saikawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Toyama Chemical Co Ltd
Original Assignee
Toyama Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP60009191A external-priority patent/JPH0629247B2/ja
Priority claimed from JP60028397A external-priority patent/JPH0629246B2/ja
Priority claimed from JP60043644A external-priority patent/JPH0665670B2/ja
Priority claimed from JP60069061A external-priority patent/JPH0665671B2/ja
Priority claimed from JP60097065A external-priority patent/JPH0662619B2/ja
Priority claimed from JP60129323A external-priority patent/JPH0665672B2/ja
Application filed by Toyama Chemical Co Ltd filed Critical Toyama Chemical Co Ltd
Publication of FR2576305A1 publication Critical patent/FR2576305A1/fr
Application granted granted Critical
Publication of FR2576305B1 publication Critical patent/FR2576305B1/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/74Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79Acids; Esters
    • C07D213/80Acids; Esters in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
FR868600871A 1985-01-23 1986-01-22 Nouveau procede de fabrication d'un derive d'(aryl substitue)-1 dihydro-1,4 oxo-4 naphtyridine, substances intermediaires utilisees pour cette fabrication et procedes de fabrication des substances intermediaires Expired - Lifetime FR2576305B1 (fr)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
JP60009191A JPH0629247B2 (ja) 1985-01-23 1985-01-23 5−フルオロニコチン酸誘導体およびその塩
JP60028397A JPH0629246B2 (ja) 1985-02-18 1985-02-18 2−(5−フルオロニコチノイル)酢酸誘導体およびその塩
JP60043644A JPH0665670B2 (ja) 1985-03-07 1985-03-07 1,4−ジヒドロ−4−オキソナフチリジン誘導体およびその塩
JP60069061A JPH0665671B2 (ja) 1985-04-03 1985-04-03 1−置換アリ−ル−1,4−ジヒドロ−4−オキソナフチリジン誘導体またはその塩の新規製造法
JP60097065A JPH0662619B2 (ja) 1985-05-08 1985-05-08 1,4−ジヒドロ−4−オキソナフチリジン誘導体またはその塩の新規製造法
JP60129323A JPH0665672B2 (ja) 1985-06-14 1985-06-14 1,4−ジヒドロ−4−オキソナフチリジン誘導体またはその塩の新規製造法

Publications (2)

Publication Number Publication Date
FR2576305A1 FR2576305A1 (fr) 1986-07-25
FR2576305B1 true FR2576305B1 (fr) 1991-04-19

Family

ID=27548185

Family Applications (1)

Application Number Title Priority Date Filing Date
FR868600871A Expired - Lifetime FR2576305B1 (fr) 1985-01-23 1986-01-22 Nouveau procede de fabrication d'un derive d'(aryl substitue)-1 dihydro-1,4 oxo-4 naphtyridine, substances intermediaires utilisees pour cette fabrication et procedes de fabrication des substances intermediaires

Country Status (20)

Country Link
US (1) US4704459A (fr)
KR (1) KR880001078B1 (fr)
AT (1) AT392789B (fr)
BE (1) BE904086A (fr)
CA (2) CA1340706C (fr)
CH (2) CH671957A5 (fr)
DE (2) DE3601517A1 (fr)
DK (3) DK169570B1 (fr)
FI (2) FI83313C (fr)
FR (1) FR2576305B1 (fr)
GB (2) GB2170804B (fr)
IL (1) IL77688A (fr)
IT (1) IT1190193B (fr)
LU (1) LU86264A1 (fr)
NL (1) NL192986C (fr)
NO (1) NO163227C (fr)
NZ (1) NZ214901A (fr)
PH (2) PH22956A (fr)
PT (1) PT81889B (fr)
SE (3) SE462164B (fr)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3525108A1 (de) * 1985-06-07 1986-12-11 Bayer Ag, 5090 Leverkusen Antibakteriell wirksame chinoloncarbonsaeureester
US4916229A (en) * 1987-07-28 1990-04-10 Warner-Lambert Company Pyridine carboxylic acid derivates
IE62600B1 (en) * 1987-08-04 1995-02-22 Abbott Lab Naphtyridine antianaerobic compounds
DE3729852A1 (de) * 1987-09-05 1989-03-23 Basf Ag Verfahren zur herstellung von 1-alkylimidazol-5-carbonsaeuren sowie deren estern, amiden und nitrilen
US4920120A (en) * 1988-01-25 1990-04-24 Warner-Lambert Company Antibacterial agents
US5585491A (en) * 1988-01-25 1996-12-17 Otsuka Pharmaceutical Co., Ltd. Antibacterial agents
US5262417A (en) * 1988-12-06 1993-11-16 The Upjohn Company Antibacterial quinolone compounds
DE3934082A1 (de) * 1989-10-12 1991-04-18 Bayer Ag Chinoloncarbonsaeurederivate, verfahren zu ihrer herstellung sowie ihre verwendung als antivirale mittel
EP0449445A3 (en) * 1990-03-27 1993-08-25 Pfizer Inc. Preparation of beta-ketoesters useful in preparing quinolone antibiotics
WO1992012155A1 (fr) * 1991-01-14 1992-07-23 Hanmi Pharmaceutical Co., Ltd. Nouveaux composes de quinoleine et leurs procedes de preparation
US5532239A (en) * 1993-08-02 1996-07-02 Assistance Publique - Hopitaux De Paris Therapeutic application of fluoroquinolone derivatives
AU679961B2 (en) * 1993-08-13 1997-07-17 Dong Wha Pharmaceutical Industrial Co., Ltd. Novel quinolone carboxylic acid derivatives
EP0788801A1 (fr) * 1994-07-20 1997-08-13 Toyama Chemical Co., Ltd. Onguent buccal a liberation prolongee
DE69802692D1 (de) 1997-06-26 2002-01-10 Dong Wha Pharm Ind Co Ltd Derivate der chinoloncarbonsäure
EP1135132A2 (fr) 1998-12-04 2001-09-26 Influx, Inc. Inhibiteurs de proteines servant a transporter plusieurs medicaments
CA2383466C (fr) 1999-09-16 2009-08-25 Tanabe Seiyaku Co., Ltd. Composes cycliques aromatiques azotes a six elements
US7273868B2 (en) * 2000-04-28 2007-09-25 Tanabe Seiyaku Co., Ltd. Pyrazine derivatives
AU2001241142B2 (en) * 2000-04-28 2005-09-22 Tanabe Seiyaku Co., Ltd. Cyclic compounds
US20080027037A1 (en) * 2000-04-28 2008-01-31 Tanabe Seiyaku Co., Ltd. Cyclic compounds
CN1503797A (zh) * 2001-02-26 2004-06-09 田边制药株式会社 吡啶并嘧啶或二氮杂萘衍生物
US6957105B2 (en) * 2002-03-26 2005-10-18 Cardiac Pacemakers, Inc. Method and apparatus for detecting oscillations in cardiac rhythm with electrogram signals
DE10312346A1 (de) * 2003-03-20 2004-09-30 Bayer Healthcare Ag Kontrolliertes Freisetzungssystem
DE10351448A1 (de) 2003-11-04 2005-06-09 Bayer Healthcare Ag Geschmackstoffhaltige Arzneimittelformulierungen mit verbesserten pharmazeutischen Eigenschaften
US7517994B2 (en) * 2003-11-19 2009-04-14 Array Biopharma Inc. Heterocyclic inhibitors of MEK and methods of use thereof
US7732616B2 (en) * 2003-11-19 2010-06-08 Array Biopharma Inc. Dihydropyridine and dihydropyridazine derivatives as inhibitors of MEK and methods of use thereof
JP4869075B2 (ja) * 2003-11-19 2012-02-01 アレイ バイオファーマ、インコーポレイテッド Mekの複素環阻害剤及びその使用方法
DE102005055385A1 (de) * 2004-12-09 2006-06-14 Bayer Healthcare Ag Arzneimittel zur hygienischen Applikation im Ohr
RU2500673C2 (ru) * 2005-05-18 2013-12-10 Астразенека Аб Гетероциклические ингибиторы мек и способы их применения
US20070197548A1 (en) * 2006-02-17 2007-08-23 Murthy Yerramilli V S Fluoroquinolone compositions
US20070196398A1 (en) * 2006-02-17 2007-08-23 Murthy Yerramilli V S Fluoroquinolone fatty acid salt compositions
US7973022B2 (en) * 2006-02-17 2011-07-05 Idexx Laboratories, Inc. Fluoroquinolone carboxylic acid salt compositions
DE102006010643A1 (de) 2006-03-08 2007-09-13 Bayer Healthcare Aktiengesellschaft Arzneimittel enthaltend Fluorchinolone
DE102006010642A1 (de) * 2006-03-08 2007-09-27 Bayer Healthcare Aktiengesellschaft Arzneimittelformulierungen, enthaltend Fluorchinolone
WO2007123939A2 (fr) * 2006-04-19 2007-11-01 Laboratoires Serono S.A. Nouveaux arylamino n-hétéraryles en tant qu'inhibiteurs de mek
DE102007026550A1 (de) * 2007-06-08 2008-12-11 Bayer Healthcare Ag Extrudate mit verbesserter Geschmacksmaskierung
DE102007055341A1 (de) * 2007-11-19 2009-05-20 Bayer Animal Health Gmbh Stabilisierung öliger Suspensionen enthaltend hydrophobe Kieselsäuren
EP2252588A2 (fr) * 2008-02-11 2010-11-24 AstraZeneca AB Procédé de préparation de dérivés de pyridone
CA2814082A1 (fr) 2010-10-12 2012-04-19 Bayer Intellectual Property Gmbh Comprimes mastiquables mous non a base d'amidon
MY175703A (en) 2012-12-19 2020-07-06 Bayer Animal Health Gmbh Tablets with improved acceptance and good storage stability
MD4291C1 (ro) * 2013-12-27 2015-02-28 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Preparat medicamentos pentru tratamentul otitelor
CA3141337A1 (fr) 2019-05-24 2020-12-03 Piedmont Animal Health Inc. Formulations injectables a liberation prolongee et leur utilisation
EP4025220A4 (fr) * 2019-09-06 2023-10-04 Elanco US Inc. Compositions vétérinaires granulaires de goût agréable

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3149104A (en) * 1961-01-03 1964-09-15 Sterling Drug Inc 4-hydroxy-7-styryl-1, 8-naphthyridine-3-carboxylic acids and esters
GB1147336A (en) * 1965-06-14 1969-04-02 Lilly Industries Ltd Quinoline-3-carboxylic acid derivatives
US3753993A (en) * 1971-05-17 1973-08-21 Sterling Drug Inc 1,4-dihydro-4-oxo-7-pyridyl-3-quinoline-carboxylic acid derivatives
DE2125310A1 (en) * 1971-05-21 1972-11-30 Sterling Drug Inc , New York, NY (V St A) 1-alkyl-1,4-dihydro-4-oxo-1,8-naphtyridine 3-carboxylic acids antibac
GB1451911A (en) * 1972-08-14 1976-10-06 Dainippon Pharmaceutical Co 2-1-piperazino-5-oxopyrido-2,3,d-pyrimidine-6-carboxylic acids their preparation and pharmaceutical compositions thereof
US4017622A (en) * 1972-12-18 1977-04-12 Dainippon Pharmaceutical Co., Ltd. Piperazine derivatives
DE2808070A1 (de) * 1978-02-24 1979-08-30 Bayer Ag Verfahren zur herstellung von 4-pyridon-3-carbonsaeuren und/oder deren derivaten
AR223983A1 (es) * 1978-08-25 1981-10-15 Dainippon Pharmaceutical Co Un procedimiento para-preparar derivados de acido 6-halogeno-4-oxo-7-(1-piperazinil)-1,8-naftiridin-3-carboxilico
US4350817A (en) * 1980-02-28 1982-09-21 American Home Products Corporation 4-Cl, Br or I-3-Carboxy or cyano-1,2-dihydro-2-oxo-1,8-naphthyridine derivatives
DE3028520A1 (de) * 1980-07-28 1982-02-25 Dynamit Nobel Ag, 5210 Troisdorf Verfahren zur herstellung von chinolinen, naphtyridinen und anderen stickstoff-bi-heterocyclen
DE3142854A1 (de) * 1981-10-29 1983-05-11 Bayer Ag, 5090 Leverkusen 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7-piperazino-chinolin-3-carbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
JPS60228479A (ja) * 1984-04-26 1985-11-13 Toyama Chem Co Ltd 1,4−ジヒドロ−4−オキソナフチリジン誘導体およびその塩

Also Published As

Publication number Publication date
IT1190193B (it) 1988-02-16
CH671957A5 (fr) 1989-10-13
GB2204040A (en) 1988-11-02
DK32286D0 (da) 1986-01-22
AT392789B (de) 1991-06-10
CA1340783C (fr) 1999-10-12
DK169570B1 (da) 1994-12-05
DK285190D0 (da) 1990-11-30
IT8647562A0 (it) 1986-01-22
SE469983B (sv) 1993-10-18
PT81889B (pt) 1988-05-27
NL8600138A (nl) 1986-08-18
FI860250A7 (fi) 1986-07-24
US4704459A (en) 1987-11-03
FI83313B (fi) 1991-03-15
SE8902264L (sv) 1989-06-21
ATA7286A (de) 1990-11-15
DK170532B1 (da) 1995-10-16
SE8902264D0 (sv) 1989-06-21
FI87647B (fi) 1992-10-30
NO163227C (no) 1990-04-25
SE469984B (sv) 1993-10-18
KR860005817A (ko) 1986-08-13
BE904086A (fr) 1986-07-22
DK285190A (da) 1990-11-30
FR2576305A1 (fr) 1986-07-25
FI893075A0 (fi) 1989-06-22
NL192986B (nl) 1998-03-02
GB2170804B (en) 1989-09-20
FI860250A0 (fi) 1986-01-20
NO163227B (no) 1990-01-15
DK32286A (da) 1986-07-24
CH667456A5 (de) 1988-10-14
CA1340706C (fr) 1999-08-17
SE8902265D0 (sv) 1989-06-21
SE462164B (sv) 1990-05-14
NZ214901A (en) 1989-01-27
GB2204040B (en) 1989-09-20
FI83313C (fi) 1991-06-25
DK285290A (da) 1990-11-30
SE8902265L (sv) 1989-06-21
DK170857B1 (da) 1996-02-12
PH22956A (en) 1989-02-03
GB2170804A (en) 1986-08-13
SE8600274D0 (sv) 1986-01-22
FI893075A7 (fi) 1989-06-22
PH23202A (en) 1989-06-06
DE3601517A1 (de) 1986-08-21
GB8601045D0 (en) 1986-02-19
IL77688A (en) 1991-01-31
DK285290D0 (da) 1990-11-30
LU86264A1 (fr) 1986-08-04
DE3637679C1 (de) 1992-08-27
FI87647C (fi) 1993-02-10
NL192986C (nl) 1998-07-03
KR880001078B1 (ko) 1988-06-22
GB8811645D0 (en) 1988-06-22
DE3601517C2 (fr) 1989-11-16
SE8600274L (sv) 1986-09-10
NO860226L (no) 1986-07-24
PT81889A (en) 1986-02-01

Similar Documents

Publication Publication Date Title
FR2576305B1 (fr) Nouveau procede de fabrication d'un derive d'(aryl substitue)-1 dihydro-1,4 oxo-4 naphtyridine, substances intermediaires utilisees pour cette fabrication et procedes de fabrication des substances intermediaires
HUT38222A (en) Herbicide and process for production of the reagents of derivatives of tetrahydrophtalimid
RO90622A (fr) Procede pour la preparation des derives de pyperidine
FR2562538B1 (fr) Procede de recristallisation d'explosifs brisants
FR2611368B1 (fr) Procede de desoxydation d'un materiau de tantale
PT84103A (en) Process for the preparation of n-containing fused heterocyclic compounds
PT81000A (en) Process for the preparation of heterocyclic derivatives
YU201085A (en) Process for obtaining of 2-(2[-substituted-benzoil)-1,3 cyclohexandione
ZA867095B (en) Process for the production of micronised waxes
FR2568570B1 (fr) Procede pour la fabrication de derives 3-substitues du 1-amino-2-hydroxypropane
FR2585948B1 (fr) Procede de fabrication de comprimes d'indometacine
RO92378A (fr) Procede pour la preparation des derives de 1,2,4-thiadiazole
DE3561805D1 (en) Process for the nuclear chlorination of toluene
FR2465730B1 (fr) Procede de preparation de melanges selectifs de piperazine et d'ethylenediamine
FR2622888B1 (fr) Procede perfectionne de synthese de la vinblastine et de la vincristine
FR2630105B1 (fr) Procede de fabrication des dialkyldisulfures inferieurs
FR2565590B1 (fr) Procede de preparation d'aminohydroxycephamcarboxylates
MA20379A1 (fr) Procede de production de 2-oxindole-1-carboxamides et de composes intermediaires correspondants
FR2576902B1 (fr) Procede de fabrication d'hydrogeno-silanes
YU44073B (en) Process for obtaining derivatives of spirothiazolidinyl piperazine
FR2618779B1 (fr) Nouveau procede de preparation des 1,2,4-triazol-3-ones
FR2568126B3 (fr) Procede de preparation d'un elixir
BE896362A (fr) Procede nouveau de production de l'aspartame
FR2615507B1 (fr) Procede de fabrication d'un compost
PT73935B (fr) Procede de preparation de (trialcoxybenzyl)-1 piperazines